NeuralBase AI Ltd., operating under its enterprise brand BMP AI, has announced the completion of the Android version of its HeartEase app, which is now undergoing final testing. The iOS version is scheduled to enter testing shortly after the Android app's public release in the coming weeks. HeartEase is an innovative application designed to offer AI-powered cardiovascular and emotional health insights through intelligent monitoring, real-time feedback, and personalized wellness recommendations.
The app utilizes NeuralBase AI’s proprietary AI platform, along with behavioral insights and biometric data analysis, to create an adaptive user experience aimed at proactive wellness management. Vighnesh Dobale, Chief Executive Officer of NeuralBase AI Ltd., highlighted the significance of this development milestone, stating it brings the company closer to launching HeartEase into the market. The app's launch is expected to validate the platform’s technology stack in real-world conditions, gather essential user feedback for further refinements, and lay the groundwork for the iOS release.
Furthermore, the deployment of HeartEase is anticipated to support potential strategic partnerships with healthcare providers, wellness platforms, and wearable technology companies. It also positions NeuralBase AI to scale its AI-powered digital health ecosystem, aligning with its mission to support enterprise wellness and preventive health diagnostics. The company plans to share updates on HeartEase’s release schedule, platform enhancements, and strategic initiatives as testing progresses.
For more information about NeuralBase AI Ltd., visit https://www.neuralbase.ai or the Securities & Exchange Commission's EDGAR database at https://www.sec.gov. The closing of the HeartEase transaction is expected by no later than September 15, 2025, with further updates to be provided as available.
